These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28485327)

  • 1. T-cell Co-inhibitory Molecules in Sepsis-induced Immunosuppression: From Bench to Bedside.
    Xie JF; Qiu HB; Yang Y
    Chin Med J (Engl); 2017 May; 130(10):1249-1252. PubMed ID: 28485327
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study progress of role of co-suppressor molecules in sepsis immune dysfunction].
    Gao J; Liu Z; Liu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):121-125. PubMed ID: 32148245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis.
    Liu Q; Li CS
    Chin Med J (Engl); 2017 Apr; 130(8):986-992. PubMed ID: 28397730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression.
    Shindo Y; Unsinger J; Burnham CA; Green JM; Hotchkiss RS
    Shock; 2015 Apr; 43(4):334-43. PubMed ID: 25565644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis.
    Cho H; Kang H; Lee HH; Kim CW
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.
    Han Y; Chen Z; Yang Y; Jiang Z; Gu Y; Liu Y; Lin C; Pan Z; Yu Y; Jiang M; Zhou W; Cao X
    Hepatology; 2014 Feb; 59(2):567-79. PubMed ID: 23960017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive immune function in critical illness.
    Doughty L
    Curr Opin Pediatr; 2016 Jun; 28(3):274-80. PubMed ID: 27054955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte programmed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study.
    Shao R; Fang Y; Yu H; Zhao L; Jiang Z; Li CS
    Crit Care; 2016 May; 20(1):124. PubMed ID: 27156867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune checkpoint modulation: rational design of combination strategies.
    Zamarin D; Postow MA
    Pharmacol Ther; 2015 Jun; 150():23-32. PubMed ID: 25583297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Immune Cell Checkpoints during Sepsis.
    Patil NK; Guo Y; Luan L; Sherwood ER
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29135922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Check Point Inhibitors and Their Role in Immunosuppression in Sepsis.
    Wakeley ME; Gray CC; Monaghan SF; Heffernan DS; Ayala A
    Crit Care Clin; 2020 Jan; 36(1):69-88. PubMed ID: 31733683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CTLA-4 and PD-1 in anti-tumor immune response and their potential efficacy against osteosarcoma.
    Wang SD; Li HY; Li BH; Xie T; Zhu T; Sun LL; Ren HY; Ye ZM
    Int Immunopharmacol; 2016 Sep; 38():81-9. PubMed ID: 27258185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.
    Attanasio J; Wherry EJ
    Immunity; 2016 May; 44(5):1052-68. PubMed ID: 27192569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.
    Hossain MS; Kunter GM; El-Najjar VF; Jaye DL; Al-Kadhimi Z; Taofeek OK; Li JM; Waller EK
    PLoS One; 2017; 12(9):e0184254. PubMed ID: 28953925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults.
    Boer MC; van Meijgaarden KE; Goletti D; Vanini V; Prins C; Ottenhoff TH; Joosten SA
    Tuberculosis (Edinb); 2016 Mar; 97():163-71. PubMed ID: 26750180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Regulatory T Cells on Promoting Apoptosis of T Lymphocyte and Its Regulatory Mechanism in Sepsis.
    Luan YY; Yin CF; Qin QH; Dong N; Zhu XM; Sheng ZY; Zhang QH; Yao YM
    J Interferon Cytokine Res; 2015 Dec; 35(12):969-80. PubMed ID: 26309018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment.
    Picchi H; Mateus C; Chouaid C; Besse B; Marabelle A; Michot JM; Champiat S; Voisin AL; Lambotte O
    Clin Microbiol Infect; 2018 Mar; 24(3):216-218. PubMed ID: 29269089
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuftsin-derived T-peptide prevents cellular immunosuppression and improves survival rate in septic mice.
    Gao YL; Chai YF; Dong N; Han S; Zhu XM; Zhang QH; Yao YM
    Sci Rep; 2015 Nov; 5():16725. PubMed ID: 26577833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of Mortality.
    Lange A; Sundén-Cullberg J; Magnuson A; Hultgren O
    PLoS One; 2017; 12(1):e0169176. PubMed ID: 28056053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.